Bristol-Myers Squibb Co. (BMY) Stock Rating

Bristol Myers Squibb discovers, develops, and markets drugs across therapeutic areas including cardiovascular disease, cancer, and immune disorders, with a particular emphasis on immuno-oncology drug development. The company generates close to 70% of total sales from the US, a greater reliance on the US market than most of its peers.

Rating as of 2026-07-07. Live price updates in real time.